Arrhythmogenic right ventricular dysplasia/cardiomyopathy

Expert Review of Cardiovascular Therapy

Volumn 6, Issue 2, 2008, Pages 249-260

  El Masry, Hicham Z ^a   Yadav, Anil V ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arrhythmogenic right ventricular dysplasia cardiomyopathy; Sudden cardiac death

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DESMOCOLLIN; DESMOCOLLIN 2; DESMOGLEIN 2; DESMOPLAKIN; PLAKOPHILIN; PLAKOPHILIN 2; RYANODINE RECEPTOR 2; SOTALOL; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

CINEANGIOGRAPHY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DEFIBRILLATOR; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; GENE DELETION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HEART ELECTROPHYSIOLOGY; HEART LEFT BUNDLE BRANCH BLOCK; HEART RIGHT BUNDLE BRANCH BLOCK; HEART RIGHT VENTRICLE DYSPLASIA; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HISTOPATHOLOGY; HOLTER MONITORING; HUMAN; MOLECULAR GENETICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PATHOPHYSIOLOGY; RADIOFREQUENCY ABLATION; REVIEW; SUDDEN DEATH; TWO DIMENSIONAL ECHOCARDIOGRAPHY; CARDIOMYOPATHY; CATHETER ABLATION; ECHOCARDIOGRAPHY; GENETICS; HEART MUSCLE; HEART SURGERY; PATHOLOGY;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CARDIAC SURGICAL PROCEDURES; CARDIOMYOPATHIES; CATHETER ABLATION; CINEANGIOGRAPHY; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HUMANS; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 40149101317     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.6.2.249     Document Type: Review

References (85)

1. Frank R, Fontaine G, Vedel J et al. Electrocardiology of 4 cases of right ventricular dysplasia inducing arrhythmia. Arch. Mal Coeur Vaiss. 71(9), 963-972 (1978).
2. Corrado, D, Basso C, Nava A, Thiene G. Arrhythmogenic right ventricular cardiomyopathy: current diagnostic and management strategies. Cardiol. Rev. 9(5), 259-265 (2001).
3. Thiene G, Basso C. Arrhythmogenic right ventricular cardiomyopathy: an update. Cardiovasc. Pathol. 10(3), 109-117 (2001).
4. Marcus FI, Fontaine GH, Guiraudon G et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation 65(2), 384-398 (1982).
5. Kies P, Bootsma M, Bax J, Schalij MJ, van der Wall EE. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: screening, diagnosis, and treatment. Heart Rhythm 3(2), 225-234 (2006).
6. Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Circulation 110(14), 1879-1884 (2004).
7. Maron BJ, Shirani J, Poliac LC, Mathenge R, Roberts WC, Mueller FO. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 276(3), 199-204 (1996).
8. Thiene G, Nava A, Corrado D, Rossi L, Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N. Engl. J. Med. 318(3), 129-133 (1988).
9. Tabib A, Loire R, Chalabreysse L et al. Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation 108(24), 3000-3005 (2003).
10. Peters S. Advances in the diagnostic management of arrhythmogenic right ventricular dysplasia-cardiomyopathy. Int. J. Cardiol. 113(1), 4-11 (2006).
11. Corrado D, Basso C, Thiene G et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/ dysplasia: a multicenter study. J. Am. Coll. Cardiol. 30(6), 1512-1520 (1997).
12. Frances RJ, Arrhythmogenic right ventricular dysplasia/cardiomyopathy. A review and update. Int. J. Cardiol. 110(3), 279-287 (2006).
13. Basso C, Thiene G, Corrado D, Angelini A, Nava A, Valente M. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? Circulation 94(5), 983-991 (1996).
14. D'Amati G, Leone O, di Gioia CR et al. Arrhythmogenic right ventricular cardiomyopathy: clinicopathologic correlation based on a revised definition of pathologic patterns. Hum. Pathol. 32(10), 1078-1086 (2001).
15. Thiene G, Basso C, Calabrese F, Angelini A, Valente M. Pathology and pathogenesis of arrhythmogenic right ventricular cardiomyopathy. Herz 25(3), 210-215 (2000).
16. Dokuparti MV, Pamuru PR, Thakkar B, Tanjore RR, Nallari P. Etiopathogenesis of arrhythmogenic right ventricular cardiomyopathy. J. Hum. Genet. 50(8), 375-381 (2005).
17. Corrado D, Basso C, Thiene G, Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart 83(5), 588-595 (2000).
18. Calabrese F, Basso C, Carturan E, Valente M, Thiene G, Arrhythmogenic right ventricular cardiomyopathy/dysplasia: is there a role for viruses? Cardiovasc. Pathol. 15(1), 11-17 (2006).
19. Calkins H. Arrhythmogenic right-ventricular dysplasia/cardiomyopathy. Curr. Opin. Cardiol. 21(1), 55-63 (2006).
20. Moric-Janiszewska E, Markiewicz-Loskot G. Review on the genetics of arrhythmogenic right ventricular dysplasia. Europace 9(5), 259-266 (2007).
21. Asimaki A, Syrris P, Wichter T, Mathias P, Saffitz JE, McKenna WJ. A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. Am. J. Hum. Genet. 81(5), 964-973 (2007).
22. McKoy G, Protonotarios N, Crosby A et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355(9221), 2119-2124 (2000).
23. Yang Z, Bowles NE, Scherer SE et al. Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ. Res. 99(6), 646-655 (2006).
24. Norman M, Simpson M, Mogensen J et al. Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy. Circulation 112(5), 636-642 (2005).
25. Rampazzo A, Nava A, Malacrida S et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am. J. Hum. Genet. 71(5), 1200-1206 (2002).
26. Pilichou K, Nava A, Basso C et al. Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation 113(9), 1171-1179 (2006).
27. van Tintelen JP, Entius MM, Bhuiyan ZA et al. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 113(13), 1650-1658 (2006).
28. Gerull B, Heuser A, Wichter T et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat. Genet. 36(11), 1162-1164 (2004).
29. Dalal, D, Molin LH, Piccini J et al. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation 113(13), 1641-1649 (2006).
30. Syrris P, Ward, D, Evans A et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. Am. J. Hum. Genet. 79(5), 978-984 (2006).
31. Tiso N, Stephan DA, Nava A et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum. Mol. Genet. 10(3), 189-194 (2001).
32. Beffagna G, Occhi G, Nava A et al. Regulatory mutations in transforming growth factor-β3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc. Res. 65(2), 366-373 (2005).
33. Dalal D, Nasir K, Bomma C et al. Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation 112(25), 3823-3832 (2005).
34. Sen-Chowdhry S, Syrris P, Ward D, Asimaki A, Sevdalis E, McKenna WJ. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 115(13), 1710-1720 (2007).
35. Corrado D, Fontaine G, Marcus FI et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Study Group on Arrhythmogenic Right Ventricular Dysplasia/ Cardiomyopathy of the Working Groups on Myocardial and Pericardial Disease and Arrhythmias of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the World Heart Federation. Circulation 101(11), E101-E106 (2000).
36. Nava A, Bauce B, Basso C et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J. Am. Coll. Cardiol. 36(7), 2226-2233 (2000).
37. Peters S. Long-term follow-up and risk assessment of arrhythmogenic right ventricular dysplasia/cardiomyopathy: personal experience from different primary and tertiary centres. J. Cardiovasc. Med. (Hagerstown) 8(7), 521-526 (2007).
38. Marcus FI, Fontaine GH, Frank R, Gallagher JJ, Reiter MJ. Long-term follow-up in patients with arrhythmogenic right ventricular disease. Eur. Heart J. 10(Suppl. D), 68-73 (1989).
39. Berder V, Vauthier M, Mabo P et al. Characteristics and outcome in arrhythmogenic right ventricular dysplasia. Am. J. Cardiol. 75(5), 411-414 (1995).
40. Pinamonti B, Di Lenarda A, Sinagra G, Silvestri F, Bussani R, Camerini F. Long-term evolution of right ventricular dysplasia-cardiomyopathy. The Heart Muscle Disease Study Group. Am. Heart J. 129(2), 412-415 (1995).
41. McKenna WJ, Thiene G, Nava A et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br. Heart J. 71(3), 215-218 (1994).
42. Hamid MS, Norman M, Quraishi A et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/ dysplasia reveals a need to broaden diagnostic criteria. J. Am. Coll. Cardiol. 40(8), 1445-1450 (2002).
43. Marcus FI. Prevalence of T-wave inversion beyond V1 in young normal individuals and usefulness for the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Am. J. Cardiol. 95(9), 1070-1071 (2005).
44. Nasir K, Bomma C, Tandri H et al. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. Circulation 110(12), 1527-1534 (2004).
45. Peters S, Trummel M, Koehler B, Westermann KU, The value of different electrocardiographic depolarization criteria in the diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Electrocardiol 40(1), 34-37 (2007).
46. Peters S, Trummel M. Diagnosis of arrhythmogenic right ventricular dysplasia-cardiomyopathy: value of standard ECG revisited. Ann. Noninvasive Electrocardiol. 8(3), 238-245 (2003).
47. Nasir K, Rutberg J, Tandri H, Berger R, Tomaselli G, Calkins H. Utility of SAECG in arrhythmogenic right ventricle dysplasia. Ann. Noninvasive Electrocardiol. 8(2), 112-120 (2003).
48. Fontaine G, Fontaliran F, Hebert JL et al. Arrhythmogenic right ventricular dysplasia. Annu. Rev. Med. 50, 17-35 (1999).
49. Perez Riera AR, Antzelevitch C, Schapacknik E, Dubner S, Ferreira C. Is there an overlap between Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia? J. Electrocardiol 38(3), 260-263 (2005).
50. Hebert JL, Chemla D, Gerard O et al. Angiographic right and left ventricular function in arrhythmogenic right ventricular dysplasia. Am. J. Cardiol. 93(6), 728-733 (2004).
51. Daliento L, Rizzoli G, Thiene G et al. Diagnostic accuracy of right ventriculography in arrhythmogenic right ventricular cardiomyopathy. Am. J. Cardiol. 66(7), 741-745 (1990).
52. Chiddo A, Locuratolo N, Gaglione A et al. Right ventricular dysplasia: angiographic study. Eur. Heart J. 10(Suppl D), 42-45 (1989).
53. Scognamiglio R, Fasoli G, Nava A, Miraglia G, Thiene G, Dalla-Volta S. Contribution of cross-sectional echocardiography to the diagnosis of right ventricular dysplasia at the asymptomatic stage. Eur. Heart J. 10(6), 538-542 (1989).
54. Manyari DE, Duff HJ, Kostuk WJ et al. Usefulness of noninvasive studies for diagnosis of right ventricular dysplasia. Am. J. Cardiol. 57(13), 1147-1153 (1986).
55. Yoerger DM, Marcus F, Sherrill D et al. Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: new insights from the multidisciplinary study of right ventricular dysplasia. J. Am. Coll. Cardiol. 45(6), 860-865 (2005).
56. Prakasa KR, Wang J, Tandri H et al. Utility of tissue Doppler and strain echocardiography in arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Am. J. Cardiol. 100(3), 507-512 (2007).
57. Auffermann W, Wichter T, Breithardt G, Joachimsen K, Peters PE. Arrhythmogenic right ventricular disease: MR imaging vs angiography. AJR Am. J. Roentgenol. 161(3), 549-555 (1993).
58. Tandri H, Castillo E, Ferrari VA et al. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J. Am. Coll. 48(11), 2277-2284 (2006).
59. Tandri H, Bomma C, Calkins H, Bluemke DA. Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia. J. Magn. Reson. Imaging. 19(6), 848-858 (2004).
60. Menghetti L, Basso C, Nava A, Angelini A, Thiene G. Spin-echo nuclear magnetic resonance for tissue characterisation in arrhythmogenic right ventricular cardiomyopathy. Heart 76(6), 467-470 (1996).
61. van der Wall EE, Kayser HW, Bootsma MM, de Roos A, Schalij MJ. Arrhythmogenic right ventricular dysplasia: MRI findings. Herz 25(4), 356-364 (2000).
62. Sen-Chowdhry S, Prasad SK, Syrris P et al. Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J. Am. Coll. Cardiol. 48(10), 2132-2140 (2006).
63. Bomma C, Rutberg J, Tandri H et al. Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Cardiovasc. Electrophysiol. 15(3), 300-306 (2004).
64. Tandri H, Saranathan M, Rodriguez ER et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J. Am. Coll. Cardiol. 45(1), 98-103 (2005).
65. Tada H, Shimizu W, Ohe T et al. Usefulness of electron-beam computed tomography in arrhythmogenic right ventricular dysplasia. Relationship to electrophysiological abnormalities and left ventricular involvement. Circulation 94(3), 437-444 (1996).
66. Bomma C, Dalal D, Tandri H et al. Evolving role of multidetector computed tomography in evaluation of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am. J. Cardiol. 100(1), 99-105 (2007).
67. Maron BJ, Chaitman BR, Ackerman MJ et al. Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation 109(22), 2807-2816 (2004).
68. Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation 86(1), 29-37 (1992).
69. Boulos M, Lashevsky I, Reisner S, Gepstein L. Electroanatomic mapping of arrhythmogenic right ventricular dysplasia. J. Am. Coll. Cardiol. 38(7), 2020-2027 (2001).
70. Marchlinski FE, Zado E, Dixit S et al. Electroanatomic substrate and outcome of catheter ablative therapy for ventricular tachycardia in setting of right ventricular cardiomyopathy. Circulation 110(16), 2293-2298 (2004).
71. Fontaine G, Tonet J, Gallais Y et al. Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia: a 16-year experience. Curr. Cardiol. Rep. 2(6), 498-506 (2000).
72. Dalal D, Jain R, Tandri H et al. Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Am. Coll. Cardiol. 50(5), 432-440 (2007).
73. Corrado D, Leoni L, Link MS et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 108(25), 3084-3091 (2003).
74. Wichter T, Paul M, Wollmann C et al. Implantable cardioverter/ defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation 109(12), 1503-1508 (2004).
75. Roguin A, Bomma CS, Nasir K et al. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Am. Coll. Cardiol. 43(10), 1843-1852 (2004).
76. Hodgkinson KA, Parfrey PS, Bassett AS et al. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). J. Am. Coll. Cardiol. 45(3), 400-408 (2005).
77. Piccini JP, Dalal D, Roguin A et al. Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. Heart Rhythm 2(11), 1188-1194 (2005).
78. Pezawas T, Stix G, Kastner J, Schneider B, Wolzt M, Schmidinger H. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/ cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up. Int. J. Cardiol. 107(3), 360-368 (2006).
79. Guiraudon GM, Klein GJ, Gulamhusein SS. Total disconnection of the right ventricular free wall: surgical treatment of right ventricular tachycardia associated with right ventricular dysplasia. Circulation 67(2), 463-470 (1983).
80. Guiraudon GM, Klein GJ, Sharma AD, Yee R, Guiraudon CM. Surgical therapy for arrhythmogenic right ventricular adiposis. Eur. Heart J. 10(Suppl. D), 82-83 (1989).
81. Cox JL, Bardy GH, Damiano RJ Jr et al. Right ventricular isolation procedures for nonischemic ventricular tachycardia. J. Thorac. Cardiovasc. Surg. 90(2), 212-224 (1985).
82. Misaki T, Watanabe G, Iwa T et al. Surgical treatment of arrhythmogenic right ventricular dysplasia: long-term outcome. Ann. Thorac. Surg. 58(5), 1380-1385 (1994).
83. Sano S, Ishino K, Kawada M et al. Total right ventricular exclusion procedure: an operation for isolated congestive right ventricular failure. J. Thorac. Cardiovasc. Surg. 123(4), 640-647 (2002).
84. Motta P, Mossad E, Savage R. Right ventricular exclusion surgery for arrhythmogenic right ventricular dysplasia with cardiomyopathy. Anesth. Analg. 96(6), 1598-1602 (2003).
85. Sen-Chowdhry S, Syrris P, McKenna WJ. Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/ cardiomyopathy. J. Am. Coll. Cardiol. 50(19), 1813-1821 (2007).